Managing T2-High Inflammation in Severe Asthma - Are Biomarkers Better Than Clinician Judgement? Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020
Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018
How to Manage Severe Asthma, the Value of Inflammation Monitoring Source: Research Seminar 2007 - Severe Asthma Year: 2007
Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study Source: International Congress 2019 – Airway diseases and blood cells Year: 2019
Problems of Importance in Severe Asthma: A Patient Perspective Source: International Congress 2019 – Person-centred approaches to COPD and asthma care Year: 2019
Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019
Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity Source: International Congress 2019 – Bronchiectasis Year: 2019
Is Virtual Autonomous Physiotherapist Tele-rehabilitation Program in Chronic Obstructive Pulmonary Disease equal to Hospital-Based Pulmonary Rehabilitation? Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine Year: 2020
Leptospirosis: An Unlikely Cause of Pulmonary Haemorrhage? Source: International Congress 2019 – Pulmonary vascular diseases? Year: 2019
Late Breaking Abstract - CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020
Impact of Eosinophilia and Time on Lung Function Decline in Adult Asthma Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary Source: Eur Respir J , 49 (3) 1700214; DOI: 10.1183/13993003.00214-2017 Year: 2017
Case Series of COVID-19 Disease in Pediatric Chronic Lung Diseases Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021
Summing Up: A Global Management of Severe Asthma Source: Research Seminar 2007 - Severe Asthma Year: 2007
The Impact of Current Smoking on Severe Asthma in the Wessex Severe Asthma Cohort Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019
Assessment of Severe Asthma Management Practices among Pulmonologists and Allergists Source: International Congress 2018 – Medical education via the web and the internet Year: 2018
Epidemiology and Triggers of Severe Asthma Source: Research Seminar 2007 - Severe Asthma Year: 2007
Study to Evaluate Satisfaction with the Inhalation Device Used by Patients with Asthma or Chronic Obstructive Pulmonary Disease and the Association with Adherence and Disease Control Source: Virtual Congress 2020 – Novel insights into nursing interventions for managing patients with asthma and COPD Year: 2020
The Effect Of An Active Exercise Program Combined With Chest Physiotherapy On Pain Severity,Posture, Respiratory Function And Quality Of Life In Patients With Chronic Obstructive Pulmonary Disease. Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases Year: 2019
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 Source: Eur Respir J, 53 (5) 1900164; 10.1183/13993003.00164-2019 Year: 2019